Skip to main content
. 2024 Mar 4;14:1336375. doi: 10.3389/fonc.2024.1336375

Table 1.

Characteristics of included literatures in this meta-analysis.

First Author Year Country Sample Age (Year) ncRNA type Detection method Classification of bladder cancer(Low/High) Sample Type
Control BCa Control BCa
Abbastabar (10) 2020 Iran 10 30 55.84 ± 11.96 57.4 ± 5.7 lncRNA qRT-PCR 13/17 Urine
lncRNA qRT-PCR 13/17 Urine
Bian (9) 2022 China 43 43 70.05 ± 12.85 71.98 ± 9.88 lncRNA qRT-PCR 9/34 Urine
Chen (23) 2020 China 120 206 / / lncRNA qRT-PCR / Serum
Chen (19) 2022 China 94 128 / / lncRNA qRT-PCR 20/108 Urine
Chen (24) 2021 China 242 242 / / lncRNA qRT-PCR / Serum
Chen (25) 2018 China 31 70 / / miRNA qRT-PCR / Serum
El-Shal (17) 2021 Egypt 28 51 58.4 ± 3.6 59.5 ± 3.2 miRNA qRT-PCR 9/42 Urine
miRNA qRT-PCR 9/42 Urine
Güllü Amuran (16) 2020 Turkey 34 105 25~87 37~87 miRNA qRT-PCR 16/89 Urine
Huang (6) 2021 China 80 80 47.4 ± 11.3 64.8 ± 12.5 lncRNA qRT-PCR 35/45 Urine
lncRNA qRT-PCR 35/45 Urine
lncRNA qRT-PCR 35/45 Urine
Lin (26) 2021 China 51 53 52–69 54–68 miRNA qRT-PCR 22/31 Urine
Wang (7) 2018 Iran 50 50 / / lncRNA qRT-PCR 31/19 Serum
Xue (8) 2017 30 30 / / lncRNA qRT-PCR / Serum
Yazarlou (14) 2018 Iran 49 59 61.28 ± 13.01 64.42 ± 15.53 lncRNA qRT-PCR 20/38 Urine
lncRNA qRT-PCR 20/38 Urine
lncRNA qRT-PCR 20/38 Urine
lncRNA qRT-PCR 20/38 Urine
Zhan (15) 2018 China 80 80 / / lncRNA qRT-PCR 50/30 Urine
lncRNA qRT-PCR 50/30 Urine
lncRNA qRT-PCR 50/30 Urine
Zhang (20) 2019 China 160 160 / / lncRNA qRT-PCR 84/76 Serum
Zheng (27) 2021 China 112 210 / / lncRNA qRT-PCR / Tissue
Zheng (21) 2018 China 50 60 67.0 ± 9.8 66.2 ± 10.7 lncRNA qRT-PCR 35/15 Plasma